🇺🇸 FDA
Pipeline program

Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers)

LIN-MD-66

Phase 3 small_molecule completed

Quick answer

Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers) for Irritable Bowel Syndrome With Constipation is a Phase 3 program (small_molecule) at IRONWOOD PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IRONWOOD PHARMACEUTICALS INC
Indication
Irritable Bowel Syndrome With Constipation
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials